Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:25 pm Unchanged | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Boxer Capital LLC | 3,192,299 5.9% | 0 (Unchanged) | View |
| 2020-02-14 4:20 pm Sale | 13G | WAVE LIFE SCIENCES LTD WVE | Boxer Capital LLC | 0 0% | -1,650,000 (Position Closed) | View |
| 2020-02-13 8:59 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Boxer Capital LLC | 3,259,764 5.7% | 100,000 (+3.16%) | View |
| 2020-02-13 3:07 pm Purchase | 13G | REVOLUTION MEDICINES INC RVMD | Boxer Capital LLC | 3,159,764 5.6% | 3,159,764 (New Position) | View |
| 2020-02-13 3:06 pm Purchase | 13G | BLACK DIAMOND THERAPEUTICS INC BDTX | Boxer Capital LLC | 2,014,858 5.6% | 2,014,858 (New Position) | View |
| 2020-02-13 3:05 pm Purchase | 13G | ARCUS BIOSCIENCES INC RCUS | Boxer Capital LLC | 3,022,391 6.6% | 3,022,391 (New Position) | View |
| 2020-02-03 4:31 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | Boxer Capital LLC | 4,425,000 5.9% | 4,425,000 (New Position) | View |
| 2019-12-13 5:12 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Boxer Capital LLC | 4,800,000 6% | 4,800,000 (New Position) | View |
| 2019-11-07 4:41 pm Purchase | 13G | CABALETTA BIO INC CABA | Boxer Capital LLC | 1,566,361 9.1% | 1,566,361 (New Position) | View |
| 2019-10-11 4:30 pm Purchase | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Boxer Capital LLC | 3,192,299 6.8% | 942,299 (+41.88%) | View |
| 2019-08-26 5:02 pm Purchase | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Boxer Capital LLC | 5,133,600 9.99% | 5,133,600 (New Position) | View |
| 2019-07-19 5:15 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 7,598,283 18.6% | 633,357 (+9.09%) | View |
| 2019-07-01 4:39 pm Purchase | 13G | ATRECA INC BCEL | Boxer Capital LLC | 1,733,583 8.3% | 1,733,583 (New Position) | View |
| 2019-05-28 4:31 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Boxer Capital LLC | 931,764 9.99% | 931,764 (New Position) | View |
| 2019-05-23 9:21 pm Purchase | 13D | MIRATI THERAPEUTICS INC MRTX | Boxer Capital LLC | 6,964,926 18.2% | 2,179,756 (+45.55%) | View |